Web Images Videos Maps News Shopping Gmail more »
Sign in
Scholar Home  
  Advanced Scholar Search
Scholar Preferences
Scholar Results 1 - 10 of about 142 citing Schupp: Molecular characterization of new selective peroxisome proliferator–activated receptor.... (0.08 sec) 

Peroxisome proliferator activated receptors as transcriptional nodal points and …

- ahajournals.org
JD Brown, J Plutzky - Circulation, 2007 - Am Heart Assoc
Peroxisome proliferator–activated receptors (PPARs) are ligand-activated transcription factors
involved in the transcriptional regulation of key metabolic pathways such as lipid
metabolism, adipogenesis, and insulin sensitivity. More recent work implicates all 3 PPAR ...
Cited by 105 - Related articles - All 8 versions

Telmisartan but not valsartan increases caloric expenditure and protects against …


K Sugimoto, NR Qi, L Kazdova, M Pravenec, T Ogihara, … - Hypertension, 2006 - Am Heart Assoc
From the Department of Laboratory Medicine (KS, NRQ, TWK), University of California, San
Francisco; Department of Geriatric Medicine (KS, TO), Osaka University Graduate School of
Medicine, Osaka, Japan; Institute for Clinical and Experimental Medicine (LK), Prague, ...
Cited by 76 - Related articles - All 6 versions

Differences in glucose tolerance between fixed-dose antihypertensive drug …

- diabetesjournals.org
G Bakris, M Molitch, A Hewkin, M Kipnes, P … - Diabetes Care, 2006 - Am Diabetes Assoc
RESEARCH DESIGN AND METHODS—A prospective, randomized, open-label, blinded–end
points design was used to assess the effects of a T/V versus L/H combination in patients with
IGT and hypertension (n = 240) followed for up to 1 year. Doses were titrated to a systolic ...
Cited by 69 - Related articles - BL Direct - All 6 versions

Selective estrogen-receptor modulators and antihormonal resistance in breast …

- ascopubs.org
VC Jordan, BW O'Malley - Journal of Clinical Oncology, 2007 - jco.ascopubs.org
Selective estrogen-receptor (ER) modulators (SERMs) are synthetic nonsteroidal compounds
that switch on and switch off target sites throughout the body. Tamoxifen, the pioneering
SERM, blocks estrogen action by binding to the ER in breast cancers. Tamoxifen has ...
Cited by 50 - Related articles - All 7 versions

Renin-angiotensin-aldosterone system and progression of renal disease

- asnjournals.org
C Ruster, G Wolf - Journal of the American Society of Nephrology, 2006 - Am Soc Nephrol
Inhibition of the renin-angiotensin-aldosterone system (RAAS) is one of the most powerful maneuvers
to slow progression of renal disease. Angiotensin II (AngII) has emerged in the past decade as
a multifunctional cytokine that exhibits many nonhemodynamic properties, such as acting ...
Cited by 48 - Related articles - BL Direct - All 5 versions

Selective PPAR modulators, dual and pan PPAR agonists: multimodal drugs for the …


B Pourcet, JC Fruchart, B Staels, C … - Expert Opin. Emerging …, 2006 - informahealthcare.com
More than 70% of patients with Type 2 diabetes mellitus (T2DM) die because of cardiovascular
diseases. Current therapeutic strategies are based on separate treatment of insulin resistance
and dyslipidaemia. Development of drugs with multimodal activities should improve ...
Cited by 40 - Related articles - BL Direct - All 6 versions

T-lymphocyte infiltration in visceral adipose tissue. a primary event in adipose …

- ahajournals.org [PDF] 
U Kintscher, M Hartge, K Hess, A Foryst- … - … , and Vascular Biology, 2008 - Am Heart Assoc
Kluwer Health, 351 West Camden Street, Baltimore, MD 21202-2436. Phone:
410-528-4050. Permissions: Permissions & Rights Desk, Lippincott Williams & Wilkins, a division
of Wolters ... T-lymphocyte Infiltration in Visceral Adipose Tissue
Cited by 44 - Related articles - All 5 versions

[PDF] Selective modulators of PPAR-γ activity: molecular aspects related to obesity and …


F Zhang, BE Lavan, FM Gregoire… - PPAR research, 2007 - hindawi.com
Page 1. Hindawi Publishing Corporation PPAR Research Volume 2007, Article ID 32696,
7 pages doi:10.1155/2007/32696 Review Article Selective Modulators of PPAR-γ Activity:
Molecular Aspects Related to Obesity and Side-Effects ...
Cited by 38 - Related articles - View as HTML - All 10 versions

Telmisartan prevents obesity and increases the expression of uncoupling protein 1 …

- ahajournals.org
K Araki, T Masaki, I Katsuragi, K Tanaka, T Kakuma, H … - Hypertension, 2006 - Am Heart Assoc
The aim of the present study was to clarify the effect of telmisartan, an angiotensin II receptor
blocker, on the development of obesity and related metabolic disorders in diet-induced obese
mice. Treatment with telmisartan dissolved in drinking water at a dosage of 5 mg/kg per ...
Cited by 32 - Related articles - All 10 versions

Telmisartan inhibits AGE-induced C-reactive protein production through …


T Yoshida, S Yamagishi, K Nakamura, T Matsui, T … - Diabetologia, 2006 - Springer
Page 1. SHORT COMMUNICATION Telmisartan inhibits AGE-induced C-reactive protein
production through downregulation of the receptor for AGE via peroxisome proliferator-activated
receptor-gamma activation T. Yoshida & S. Yamagishi & K. Nakamura & T. Matsui & ...
Cited by 33 - Related articles - BL Direct - All 5 versions


Result Page: 

1

2

3

4

5

6

7

8

9

10

Next


 


Go to Google Home - About Google - About Google Scholar

©2009 Google